SCUDERI, Sarah Adriana
 Distribuzione geografica
Continente #
EU - Europa 2.303
NA - Nord America 1.738
AS - Asia 1.278
SA - Sud America 337
AF - Africa 39
OC - Oceania 8
Totale 5.703
Nazione #
US - Stati Uniti d'America 1.668
RU - Federazione Russa 1.414
SG - Singapore 555
CN - Cina 266
BR - Brasile 263
IE - Irlanda 215
IT - Italia 198
SE - Svezia 155
HK - Hong Kong 132
VN - Vietnam 92
DE - Germania 77
FR - Francia 71
IN - India 59
CA - Canada 33
GB - Regno Unito 32
AR - Argentina 29
MX - Messico 27
FI - Finlandia 23
NL - Olanda 22
PL - Polonia 21
IR - Iran 20
ID - Indonesia 19
TR - Turchia 19
JP - Giappone 18
BD - Bangladesh 17
ZA - Sudafrica 17
ES - Italia 14
PK - Pakistan 14
AT - Austria 13
EC - Ecuador 13
IQ - Iraq 12
UA - Ucraina 10
VE - Venezuela 10
CO - Colombia 9
UZ - Uzbekistan 9
CL - Cile 8
TN - Tunisia 8
TW - Taiwan 8
AU - Australia 6
BE - Belgio 6
NO - Norvegia 5
DZ - Algeria 4
HU - Ungheria 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
DK - Danimarca 3
KR - Corea 3
LT - Lituania 3
PH - Filippine 3
PS - Palestinian Territory 3
TH - Thailandia 3
BG - Bulgaria 2
BY - Bielorussia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
IL - Israele 2
JO - Giordania 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
IS - Islanda 1
KE - Kenya 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 5.703
Città #
Ashburn 438
Moscow 401
Singapore 286
Dublin 215
Chandler 198
Dallas 137
Hong Kong 126
Nyköping 124
San Jose 99
Beijing 77
The Dalles 67
New York 61
Messina 51
Los Angeles 47
Munich 38
Lauterbourg 30
Princeton 27
São Paulo 27
Redondo Beach 26
Hanoi 23
Boardman 22
Buffalo 21
Ho Chi Minh City 20
Medford 20
Warsaw 17
Montreal 16
Rome 16
Council Bluffs 15
Des Moines 15
Stockholm 15
Tianjin 15
Frankfurt am Main 14
Orem 14
Tokyo 14
Chennai 12
Rio de Janeiro 12
Palermo 11
San Francisco 11
Amsterdam 10
Guangzhou 10
Jakarta 10
Santa Clara 10
Wilmington 10
Mumbai 9
Nuremberg 9
Shanghai 9
Tashkent 9
Atlanta 8
Denver 8
London 8
Turku 8
Baghdad 7
Catania 7
Chicago 7
Gentilly 7
Helsinki 7
Lappeenranta 7
Mexico City 7
Poplar 7
Brooklyn 6
Brussels 6
Düsseldorf 6
Falls Church 6
Naples 6
Pune 6
Boston 5
Caracas 5
Da Nang 5
Hyderabad 5
Istanbul 5
Johannesburg 5
Manchester 5
Phoenix 5
Quito 5
Toronto 5
Vienna 5
Yuanlin 5
Cagliari 4
Campinas 4
Curitiba 4
Godoy Cruz 4
Lucca 4
Milan 4
Paris 4
Salvador 4
Santiago 4
Shenzhen 4
Tunis 4
Turin 4
Washington 4
Ankara 3
Bengaluru 3
Biên Hòa 3
Bogotá 3
Brasília 3
Buenos Aires 3
Canicattini Bagni 3
Carney 3
Charlotte 3
Corigliano Calabro 3
Totale 3.130
Nome #
Influence of coagulase-negative staphylococci as potential probiotics on Dry Eye 212
BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine 193
Co-Ultra PEALut Enhances Endogenous Repair Response Following Moderate Traumatic Brain Injury 187
Beneficial effect of KYP-2047, a propyl-oligopeptidase inhibitor, on oral squamous cell carcinoma 187
Antioxidant and anti-inflammatory effect of nrf2 inducer dimethyl fumarate in neurodegenerative diseases 183
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis 180
Involvement of TBK1 and PREP signalling pathways in Glioblastoma Multiforme progression: novel therapeutic perspectives 172
Evaluation of a Product Containing Xyloglucan and Pea Protein on Skin Barrier Permeability 169
The protective role of prolyl oligopeptidase (pop) inhibition in acute lung injury induced by intestinal ischemia-reperfusion 159
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model 149
Therapeutic potential of flavonoids in the treatment of chronic venous insufficiency 148
KYP-2047, an inhibitor of prolyl-oligopeptidase, reduces glioblastoma proliferation through angiogenesis and apoptosis modulation 135
NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression 129
GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways 126
Neuroprotective effects of GSK-343 in an in vivo model of MPTP-induced nigrostriatal degeneration 126
Therapeutic Potential of BAY-117082, a Selective NLRP3 Inflammasome Inhibitor, on Metastatic Evolution in Human Oral Squamous Cell Carcinoma (OSCC) 124
Effect of Melatonin on Psoriatic Phenotype in Human Reconstructed Skin Model 124
Stafilococchi coagulasi-negativi potenziali probiotici per il Dry Eye 123
Poly (Adp-ribose) polymerase inhibitor, abt888, improved cisplatin effect in human oral cell carcinoma 122
EZH2 Inhibition to Counteract Oral Cancer Progression through Wnt/β-Catenin Pathway Modulation 118
Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling 114
Modulation of NLRP3 inflammasome attenuated inflammatory response associated to diarrhea-predominant irritable bowel syndrome 114
The inhibition of prolyl oligopeptidase as new target to counteract chronic venous insufficiency: Findings in a mouse model 113
Synergic therapeutic potential of PEA-Um treatment and NAAA enzyme silencing in the management of neuroinflammation 113
Pea-oxa mitigates oxaliplatin-induced painful neuropathy through nf-κb/nrf-2 axis 109
ABCB1-Mediated Colchicine Transport and Its Implications in Familial Mediterranean Fever: A Systematic Review 109
Role of ABT888, a Novel Poly(ADP-Ribose) Polymerase (PARP) Inhibitor in Countering Autophagy and Apoptotic Processes Associated to Spinal Cord Injury 106
Effect of a combination of pea protein, grape seed extract and lactic acid in an in vivo model of bacterial vaginosis 103
Role of fibroblast growth factors receptors (FGFRs) in brain tumors, focus on astrocytoma and glioblastoma 102
Pentraxin 3: A Main Driver of Inflammation and Immune System Dysfunction in the Tumor Microenvironment of Glioblastoma 91
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis 90
TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells 87
Casein Kinase 2 Inhibitor, CX-4945, Induces Apoptosis and Restores Blood-Brain Barrier Homeostasis in In Vitro and In Vivo Models of Glioblastoma 85
The inhibition of mammalian target of rapamycin (mTOR) in improving inflammatory response after traumatic brain injury 85
Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine 83
Ulva pertusa, a Marine Green Alga, Attenuates DNBS-Induced Colitis Damage via NF-κB/Nrf2/SIRT1 Signaling Pathways 80
The Impact of COVID-19 on Amputation and Mortality Rates in Patients with Acute Limb Ischemia: A Systematic Review and Meta-Analysis 78
An Updated and Comprehensive Review Exploring the Gut–Brain Axis in Neurodegenerative Disorders and Neurotraumas: Implications for Therapeutic Strategies 75
Targeting enhancer of zeste homolog 2: A novel therapeutic approach for head and neck cancer 71
The Biological Function of MicroRNAs in Bone Tumors 65
Protective Effect of Probiotics against Pseudomonas aeruginosa Infection of Human Corneal Epithelial Cells 65
Synergistic Effect of Plant Compounds in Combination with Conventional Antimicrobials against Biofilm of Staphylococcus aureus, Pseudomonas aeruginosa, and Candida spp. 63
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival 60
Linking GERD and the Peptide Bombesin: A New Therapeutic Strategy to Modulate Inflammatory, Oxidative Stress and Clinical Biochemistry Parameters 60
Marine Algae and Deriving Biomolecules for the Management of Inflammatory Bowel Diseases: Potential Clinical Therapeutics to Decrease Gut Inflammatory and Oxidative Stress Markers? 60
The Therapeutic Potential of MicroRNA-21 in the Treatment of Spinal Cord Injury 59
Potential preventive role of probiotics against Pseudomonas aeruginosa corneal infection 59
Ulva pertusa Modulated Colonic Oxidative Stress Markers and Clinical Parameters: A Potential Adjuvant Therapy to Manage Side Effects During 5-FU Regimen 57
The Gut–Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy 55
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis 53
PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro Models 53
Atlas of expression of acyl CoA binding protein/diazepam binding inhibitor (ACBP/DBI) in human and mouse 52
A Chemically Defined TLR3 Agonist with Anticancer Activity 49
Orthotopic model of tongue cancer for the study of head and neck squamous cell carcinoma in mice 35
Aesculus hippocastanum Extract Exerts Neuroprotective Effects in an MPP+-Induced Parkinson's Disease Model via PPARγ Activation 26
Inhibition of Enhancer of Zeste Homolog 2 alleviates oxidative stress, inflammation and barrier damage of human corneal epithelial cells 23
Troxerutin Potentiated Temozolomide Induced Antitumor Effect in 2D and 3D Glioblastoma Models 18
TOPICAL APPLICATION OF LACTOBACILLUS REUTERI IN PREVENTION AND MANAGEMENT OF STAPHYLOCOCCUS AUREUS CORNEAL INFECTION 17
null 15
Probiotic bacteria reduce damages of pretreated epithelial corneal cells due to pathogens infections 9
Totale 5.827
Categoria #
all - tutte 18.915
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.915


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 1 1 1
2021/2022192 0 6 10 12 18 7 7 7 17 3 29 76
2022/2023654 52 65 29 53 43 69 6 39 261 10 22 5
2023/2024249 7 28 10 18 29 80 11 12 0 9 6 39
2024/20251.046 46 25 50 47 61 47 46 143 227 78 127 149
2025/20263.648 225 206 233 263 388 737 448 456 486 206 0 0
Totale 5.827